“…In particular, several studies on SARS-CoV-2 support the presence of intra-host genomic diversity in clinical samples and primary isolates (Ramazzotti et al, 2020; Shen et al, 2020; Wölfel et al, 2020; Capobianchi et al, 2020; Rose et al, 2020; Lu et al, 2020; Lythgoe et al, 2020; Seemann et al, 2020; Popa et al, 2020), whereas similar results were obtained on SARS-CoV (Xu et al, 2004), MERS (Park et al, 2016), EBOLA (Ni et al, 2016) and H1N1 influenza (Poon et al, 2016). We here present one of the the largest up-to-date studies on intra-host genomic diversity of SARS-CoV-2, based on a large dataset including 1133 high-quality samples for which raw sequencing data are available (NCBI BioProject: ).…”